Impact of real-world off-label dose of Apixaban on long-term clinical outcomes in patients with atrial fibrillation and chronic kidney disease

被引:0
|
作者
Im, S. I. [1 ]
Shin, H. S. [1 ]
机构
[1] Kosin Univ, Gospel Hosp, Pusan, South Korea
关键词
D O I
10.1093/eurheartj/ehae666.589
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Impact of atrial fibrillation on long-term clinical outcomes in heart failure outpatients
    Kaneko, H.
    Suzuki, S.
    Yajima, J.
    Oikawa, Y.
    Sagara, K.
    Otsuka, T.
    Matsuno, S.
    Kano, H.
    Aizawa, T.
    Yamashita, T.
    EUROPEAN HEART JOURNAL, 2013, 34 : 297 - 297
  • [42] Clinical outcomes and predictors of long-term mortality, hemorrhagic and thromboembolic events in atrial fibrillation patients at different stages of chronic kidney disease: The CRAFT trial
    Styczkiewicz, Marek
    Wawrzencyk, Mateusz
    Peller, Micha l
    Krzowski, Bartosz
    Maciejewski, Cezary
    Lodzinski, Piotr
    Kraj, Leszek
    Opolski, Grzegorz
    Grabowski, Marcin
    Balsam, Pawe l
    IJC HEART & VASCULATURE, 2023, 49
  • [43] Characteristics and Outcomes in Patients With Atrial Fibrillation (af) Receiving Direct Oral Anticoagulants (doacs) in off-Label Dose.
    Sarrazin, Vaughan Mary S.
    Briasoulis, Alexandros
    Leira, Enrique C.
    STROKE, 2019, 50
  • [44] Off-label reduced-dose apixaban does not reduce hemorrhagic risk in Taiwanese patients with nonvalvular atrial fibrillation A retrospective, observational study
    Chen, I-Chih
    Chang, Wei-Ting
    Hsu, Po-Chao
    Yeh, Ya-Lan
    Zheng, Syuan
    Huang, Yuan-Chi
    Lin, Chih-Hsien
    Tsai, Liang-Miin
    Lin, Li-Jen
    Liu, Ping-Yen
    Liu, Yen-Wen
    MEDICINE, 2021, 100 (23) : E26272
  • [45] Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study
    Kavati, Abhishek
    Zhdanava, Maryia
    Ortiz, Benjamin
    LeCocq, Jason
    Schiffman, Bradd
    Pion, Dominic
    Cheung, Hoi Ching
    Lefebvre, Patrick
    Stone, Brian D.
    ALLERGY AND ASTHMA PROCEEDINGS, 2019, 40 (05) : 321 - 328
  • [46] Real-World Treatment Patterns and Long-Term Clinical Outcomes in Thai Patients With Acquired Haemophilia A
    Hantrakun, Nonthakorn
    Niprapan, Piangrawee
    Tuntivate, Pakinee
    Wongsarikan, Nuttanun
    Norasetthada, Lalita
    Tantiworawit, Adisak
    Rattarittamrong, Ekarat
    Chai-Adisaksopha, Chatree
    Rattanathammethee, Thanawat
    Hantrakool, Sasinee
    Piriyakhuntorn, Pokpong
    Punnachet, Teerachat
    HAEMOPHILIA, 2025,
  • [47] LONG-TERM CLINICAL OUTCOMES OF SIROLIMUS ELUTING STENTS IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Sagara, Shuichiro
    Fukushima, Yusuke
    Inoue, Yohei
    Nakama, Tatsuya
    Mine, Daigo
    Nishihira, Kensaku
    Ashikaga, Keiichi
    Nomura, Katsumasa
    Kuriyama, Nehiro
    Matsuyama, Akihiko
    Shibata, Yoshisato
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1839 - E1839
  • [48] Clinical outcomes following "off-label" versus "established" indications of bioresorbable scaffolds for the treatment of coronary artery disease in a real-world population
    Miyazaki, Tadashi
    Ruparelia, Neil
    Kawamoto, Hiroyoshi
    Figini, Filippo
    Latib, Azeem
    Colombo, Antonio
    EUROINTERVENTION, 2016, 11 (13) : 1475 - 1478
  • [49] Reply: How to Demonstrate the Clinical Impact of Off-Label Use of Direct Oral Anticoagulants in Patients With Atrial Fibrillation
    Kino, Tabito
    Nogami, Akihiko
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2025,
  • [50] Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience
    Talerico, Rosa
    Brando, Elisa
    Luzi, Lorenzo
    Vedovati, Maria Cristina
    Giustozzi, Michela
    Verso, Melina
    Di Gennaro, Leonardo
    Basso, Maria
    Ferretti, Antonietta
    Porfidia, Angelo
    De Candia, Erica
    Pola, Roberto
    Agnelli, Giancarlo
    Becattini, Cecilia
    INTERNAL AND EMERGENCY MEDICINE, 2024, : 1645 - 1652